These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 6147706)

  • 1. Screening and breast cancer.
    Verbeek AL; Hendriks JH; Holland R; Mravunac M; Sturmans F; Day NE; Collette HJ; Rombach JJ; de Waard F
    Lancet; 1984 Sep; 2(8404):690. PubMed ID: 6147706
    [No Abstract]   [Full Text] [Related]  

  • 2. Reduction of breast cancer mortality through mass screening with modern mammography. First results of the Nijmegen project, 1975-1981.
    Verbeek AL; Hendriks JH; Holland R; Mravunac M; Sturmans F; Day NE
    Lancet; 1984 Jun; 1(8388):1222-4. PubMed ID: 6144933
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Concepts and problems in the evaluation of screening programs.
    Prorok PC; Hankey BF; Bundy BN
    J Chronic Dis; 1981; 34(4):159-71. PubMed ID: 7014584
    [No Abstract]   [Full Text] [Related]  

  • 4. Review of mortality results in randomised trials in early breast cancer.
    Lancet; 1984 Nov; 2(8413):1205. PubMed ID: 6150246
    [No Abstract]   [Full Text] [Related]  

  • 5. Screening, detection, and diagnosis of breast cancer.
    Miller AB; Bulbrook RD
    Lancet; 1982 May; 1(8281):1109-11. PubMed ID: 6122901
    [No Abstract]   [Full Text] [Related]  

  • 6. [The scientific basis for population screening for breast cancer in the Netherlands].
    de Koning HJ; Fracheboud J; Verbeek AL; Rutgers EJ; van der Maas PJ
    Ned Tijdschr Geneeskd; 2002 Jun; 146(22):1034-41. PubMed ID: 12073506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of nationwide cancer-screening programmes.
    de Koning HJ
    Lancet; 2000 Jan; 355(9198):80-1. PubMed ID: 10675158
    [No Abstract]   [Full Text] [Related]  

  • 8. Randomized clinical trials in breast cancer: a tabular summary. Part 2: Advanced breast cancer.
    Kieser R; Conrad B
    Arch Geschwulstforsch; 1987; 57(4):323-49. PubMed ID: 3314771
    [No Abstract]   [Full Text] [Related]  

  • 9. Axillary samples in breast cancer.
    Lancet; 1982 Jul; 2(8288):37-8. PubMed ID: 6123762
    [No Abstract]   [Full Text] [Related]  

  • 10. [The benefit of population screening for breast cancer; an advisory report from the Health Council of the Netherlands].
    van Veen WA; Knottnerus JA
    Ned Tijdschr Geneeskd; 2002 Jun; 146(22):1023-6. PubMed ID: 12073502
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Population screening for breast cancer by mammography in The Netherlands. Expectations, early results, negative effects and conditions for large-scale screening.
    Hendriks JH; Verbeek AL
    Diagn Imaging Clin Med; 1985; 54(3-4):186-91. PubMed ID: 3896616
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Therapeutic trial of Poly(A).Poly(U) adjuvant immunotherapy in operable cancer of the breast. Long-term results].
    Lacour J; Lacour F; Ducot B; Spira A; Michelson M; Petit JY; Sarrazin D; Contesso G
    Chirurgie; 1988; 114(6):516-23. PubMed ID: 3067998
    [No Abstract]   [Full Text] [Related]  

  • 13. The Canadian National Breast Screening Studies are compromised and their results are unreliable. They should not factor into decisions about breast cancer screening.
    Kopans DB
    Breast Cancer Res Treat; 2017 Aug; 165(1):9-15. PubMed ID: 28528449
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening mammography re-evaluated.
    Cates C; Senn S
    Lancet; 2000 Feb; 355(9205):750; author reply 752. PubMed ID: 10703824
    [No Abstract]   [Full Text] [Related]  

  • 15. Randomized clinical trials in breast cancer: a tabular summary. Part 1: Primary breast cancer.
    Conrad B; Kieser R
    Arch Geschwulstforsch; 1986; 56(3):211-36. PubMed ID: 3524501
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduction in mortality from breast cancer after mass screening with mammography. Randomised trial from the Breast Cancer Screening Working Group of the Swedish National Board of Health and Welfare.
    Tabár L; Fagerberg CJ; Gad A; Baldetorp L; Holmberg LH; Gröntoft O; Ljungquist U; Lundström B; Månson JC; Eklund G
    Lancet; 1985 Apr; 1(8433):829-32. PubMed ID: 2858707
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Positive effects of breast cancer screening on mortality from breast cancer: 17 year DOM-project in Utrecht evaluated with a case control study].
    Broeders MJ; Peer PG; Verbeek AL
    Ned Tijdschr Geneeskd; 1999 Mar; 143(13):698-9. PubMed ID: 10321309
    [No Abstract]   [Full Text] [Related]  

  • 18. Surgical biopsy of non-palpable mammary lesions. Technique and results.
    Arnesson LG; Fagerberg G; Gröntoft O; Lundström B
    Acta Chir Scand; 1986 Feb; 152():97-101. PubMed ID: 3513472
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Size of phase III cancer clinical trials.
    Simon R
    Cancer Treat Rep; 1985 Oct; 69(10):1087-93. PubMed ID: 4042088
    [No Abstract]   [Full Text] [Related]  

  • 20. Breast screening: new evidence.
    Lancet; 1984 Jun; 1(8388):1217-8. PubMed ID: 6144928
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.